L6 Strengthening the global drug control framework: a path to effective implementation E/CN.7/2025/L.6 Colombia: we updated the document to reflect all recent agreements from last night, we are still working hard with delegations to find consensus across the document Chair: We start with deliberating the title, the floor is open. Sudan: it was only …
France
Committee of the Whole – Wednesday afternoon
L3. Promoting research on evidence-based interventions for the treatment and care of stimulant use disorders E/CN.7/2025/L.3 (…) Chair: There are several paragraphs in this document that have been agreed during informals, so we will go through those first. PP1 Agreed in CoW. PP4 Agreed in CoW. PP5 Agreed in CoW PP8 Agreed in CoW PP10 …
Committee of the Whole – Wednesday morning session
L.5. Safety of officers in dismantling illicit synthetic opioid laboratories OP 2 (c) (…) China: We would like to delete the wording from ‘exposure’ to ‘chemicals’. United States: WE would like to remain faithful to the intention of sponsors, which is in line with our policy. This resolution is for all member states but some …
Committee of the Whole — Monday afternoon session
L.2. Promoting comprehensive, scientific evidence-based and multisectoral national systems of drug use prevention for children Chair: Welcome to the first CoW for the 68th CND session. This committee will have eight meetings, starting this afternoon through to Friday morning. We will suspend our work on Wednesday morning when voting in-person on agenda number 5. A …
Item 3. General Debate (Cont.)
Item 3. General Debate (Cont.) Iran. I wish to congratulate you for your election. I wish to thank the executive director for organizing this. The global issue of narcotic drugs is undergoing big issues. We are witnessing the emergence of NPS that have challenged monitoring and controlling systems. In order to have a more effective …
CND Intersessional – Session 5 – Legal, Scientific, and Regulatory Challenges in Scheduling Substances
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Good Morning. Secretariat: (organizational matters + scheduling 101) Moderator/intro: Mr. Justice Tettey, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC: Good morning, dear colleagues. Thank you for this opportunity to address the question you posed about …